版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
免疫應(yīng)答概論2lightchains(or)2heavychains(5isotypes:IgG,M,A,D,E)2Bindingsites(Divalent)SecretedintocirculationBindsSolubleAntigen2Chains/(95%)or/(5%)1Bindingsite(Monovalent)MembraneBound,NotSecretedBindsAntigenComplexedwithMHCZap70fynlckgezVVCCCH1CH2CH3CH2CH3CH1CLCLVLVLVHVHedzIga/IgbIga/IgbBlk,FynorLynBandTLymphocyteAntigenReceptorsBDC2021/4/272XPID:X-linkedpolyendocrinopathy,immunedysfunctionanddiarrheaXLAAD:“AutoimmunityAllergicDysreg”Scurfingene(Foxp3/JM2)Immunopathogenesis:Th2Cytokines,abnormalactivation(Il-4,5,13)
-Scurfy+Nude:NoAutoimmunity
-CD4+intoNude:Disease
-BoneMarrowintoirradiated:NoDisease
-RequireAntigenStimulationforDisease
-MixedChimera:NoDiseaseBDC2021/4/273HumanLeukocyteAntigenhumanMHCcell-surfaceproteinsimportantinselfvs.nonselfdistinctionpresentpeptideantigenstoTcellsCLASSI:A,B,CCLASSII:DR,DQ,DPHLAJ.Noble2021/4/274TheHumanLeukocyteAntigenComplex(6p21.31)DPDQDRBCAClassII
(1.1Mb)ClassIIIClassI(2.2Mb)ComplementandCytokinesClassI-likegenesandpseudogenesFrequentRecombinationRecombinationisRareTelomereCentromereRecombinationisRare(0.7Mb)BDC2021/4/275a3b2a1a2a1a2b1b2Binds8-10mersExpressedonmostNucleatedcellsPresentsCytosolicProteinstoCD8+TcellsBinds13-25mersExpressedonAPCs,Macs,Bcells,activatedTcellsPresentsVesicularProteinstoCD4+TcellsClassI ClassIIHLAClassIandIIMoleculesHaveaDistinctStructureandFunctionBDC2021/4/2760501
020103010302ciscisDQA1 DQB1transDQA1*0301/DQB1*0201DQA1*0501/DQB1*0302DQA1*0501/DQB1*0201DQA1*0301/DQB1*0302MaternalPaternalCisandTrans-ClassIIDimerizationBDC2021/4/277DQB1*0402Asp57Leu56-chain-chainBDCBDC2021/4/278HLA-Peptide:TCRCDR1CDR2CDR3CDR3CDR2CDR1NH3+COO-TCRalphaTCRbeta2Helixα1HelixBDC2021/4/279Co-Stimulation
TCellAPCCTLA-4-CD28+CD154(CD40L)CD2CD58CD40B7(+)IL-1,IL-6,TNFIL-10TGF(-)TCR-MHCBDC2021/4/2710AbsenceofSignal2ActivationClonalAnergyorDeletionTCRMHCAPCToleranceTCellTCRMHCAPCSignal1+Signal2B7TCellcytokinesCD28The2-SignalModelofLymphocyteActivationBDC2021/4/2711MHC/self-peptideCD4MHC/VbCD4CD4+VbxTcell
APCActivatedautoreactiveCD4+TCRVbxTH1cell
TCRVbxTCRVbx(1)expansionofCD4+,autoreactiveTH1cellsspecificforautoantigens(2)migrationandinfiltrationoftheseselfreactiveCD4+TH1cellsintotissuesandinductionofinflammationandautoimmunity(3)inductionofregulatorycellswhichcontrolthegrowthandactivationofthepathogenicautoreactiverepertoireofCD4+TcellsInductionofCD4+TH1mediatedautoimmunity:Aparadigmforthepathogenesisofrheumatoidarthritis,multiplesclerosisandtypeIdiabetesL.Chess20022021/4/2712TH1CD4+cellsTH2CD4+cellsCD8orCD4suppressorprecursorCD8orCD4suppressoreffectorActivatedCD4Tcellspeptide/APC
RegulatoryimmunityCD4/CD8interactions(-)(-)TheControlofActivatedCD4+TCellsbyRegulatoryTcellsApoptosisRestingCD4TcellsIL-12/IFN-gIL-4NKTcells/CD4+CD25+cellsCD4+CD25-cells(-)(-)IL-10IFN-gL.Chess20022021/4/2713TcellactivationisregulatedbysignalsderivedfromtheTCR/CD3/CD4complexandtheCD40LandCD28/CTLA-4co-stimulatorymolecules
gedzzCD3MHCclassII
a,b
TCRhhPeptideantigenCD4+
TCell
AntigenPresentingCell(APC)VaVbCaCbCD4AntigenspecificTCRsignalsCD40CD40LsignalCD28/CTLA-4CD80(B7.1)/CD86(B7.2)lckCo-stimulatorysignals(-)/[+][+]L.Chess20022021/4/2714gedVaCaCbVbzzp56lck
peptideCD3CD28CD40LFA-3LFA-1ICAM-1MHCIIB7CD40LCD4CD45TCRCD2CD4+TCellAPC/BcellhhMolecularInteractionsofHelperTCellsandAPCB7CTLA-4VLA-1CollagenCD80/CD86L.Chess20022021/4/2715MHC/peptideTCRQa-1/VbActivatedCD4+TcellRestingCD4+TcellDown-regulationofActivatedCD4+TCellsTcellactivationinducesexpressionoffunctionalTcellsurfacemoleculesRegulatoryCD8+TcellTCR
(anti-Qa-1/Vb)
ActivatedCD8+Tcell(+)(-)TCRAPCTCRLateActivatedCD4+TcellVLA-1CollagenCD40LMigrationofsitesofinflammationInductionandactivationofBcellsAPCsCD25L.Chess20022021/4/2716ActivatedTH1CD4+TCellCD4+Cell(TH2)CD4+Cell(TH0)DR3,DR4,,DQ8/insulinpeptide
CD2Macrophage/dendriticcellFcR
IFN-g
IL-12CD40LCD40a,b,TCRIL-1,TNF,LT,NO,PGE-2BCell?anti-insulin,GADabanti-MogIL-4ImmunopathophysiologyofDiabetes?AntibodymediatedinjuryDendriticcell/APCCD40LIL-4CD40LCD8+CTLFasLperforinbcelldeathbisletcellsL.Chess20022021/4/2717InnateImmuneSystem:Toll-likereceptoractivationofAPC
TCellCD28B7TCR-MHCLPSTollLikeReceptor(patternRecognitionR)IL-1,6,12“Signal3”Signal2Signal1AnitgenPresentingCell(APC)BDC2021/4/2718Th1vs.Th2CD4TCellsTh1IL-12fordifferentiationCytokines:
Interferon-
Interleukin-2IntracellularPathogensCD8CytotoxicityDelayedTypeHypersensitivityMacrophageActivationTh2IL-4fordifferentiationCytokines:
Inerluekin-4
Inter
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 數(shù)學(xué)內(nèi)加外減的題目及答案
- 數(shù)據(jù)挖掘模型調(diào)優(yōu)方法
- 2026年及未來(lái)5年市場(chǎng)數(shù)據(jù)中國(guó)咖啡廳行業(yè)市場(chǎng)深度分析及發(fā)展趨勢(shì)預(yù)測(cè)報(bào)告
- 診所急重癥搶救制度
- 設(shè)備維修保養(yǎng)制度管理制度
- 解毒王二明獎(jiǎng)金制度
- 2025年水利廳所屬事業(yè)單位考試及答案
- 2025年java牛客筆試題庫(kù)及答案
- 2025年鄆城縣人事考試及答案
- 2026年及未來(lái)5年市場(chǎng)數(shù)據(jù)中國(guó)糧食物流行業(yè)市場(chǎng)調(diào)查研究及投資前景展望報(bào)告
- 殯葬禮儀服務(wù)創(chuàng)新創(chuàng)業(yè)項(xiàng)目商業(yè)計(jì)劃書
- 數(shù)據(jù)驅(qū)動(dòng)的零售商品陳列優(yōu)化方案
- 顱內(nèi)感染指南解讀
- 四川省成都市2025年中考語(yǔ)文真題試卷
- 2025年中國(guó)蠕變?cè)囼?yàn)機(jī)數(shù)據(jù)監(jiān)測(cè)研究報(bào)告
- 蘇東坡傳全書課件
- 員工利益沖突風(fēng)險(xiǎn)識(shí)別與應(yīng)對(duì)
- 公司cqc標(biāo)志管理辦法
- 2025年日本市場(chǎng)數(shù)字廣告投放洞察報(bào)告-Sensor Tower
- 繩索救援系統(tǒng)教學(xué)課件
- 統(tǒng)編版語(yǔ)文六年級(jí)下冊(cè)小升初課內(nèi)閱讀專項(xiàng)訓(xùn)練-(含答案)
評(píng)論
0/150
提交評(píng)論